Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience

Eye

Volumn 16, Issue 3, 2002, Pages 304-308

  Young, A L ^a   Rao, S K ^a   Cheng, L L ^a   Wong, A K K ^a   Leung, A T S ^a   Lam, D S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allograft rejection; Corneal transplant; Corticosteroids; Cyclosporine A; Methyl prednisolone

Indexed keywords

CREATININE; CYCLOSPORIN A; FLUOROMETHOLONE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; EXPERIENCE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HUMAN; LIVER TOXICITY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036275709     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700144     Document Type: Article

References (17)

1. Immunologically privileged sites
2. Corneal graft survival and visual outcome: A multicentre study
3. Corticosteroids in corneal graft rejection. Oral versus single pulse therapy
4. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection
5. Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment
6. The use of a single pulse of intravenous methyl prednisolone in the treatment of corneal graft rejection. A preliminary report
7. Effectiveness of histocompatibility matching in high-risk corneal transplantation
8. The use of cyclosporine in high-risk keratoplasty
9. Cyclosporine in the treatment of acute cadaveric kidney graft rejection refractory to high-dose methyl prednisolone
10. The use of combined intravenous pulse methyl prednisolone and oral cyclosporine A in the treatment of corneal graft rejection: A preliminary study
11. The use of combined intravenous pulse methyl prednisolone and low-dose oral cyclosporine A in the treatment of corneal graft rejection: Addendum to previous report
12. Mechanism of action of cyclosporin: Effect on cells of the immune system and on subcellular events in T cell activation
13. Randomised controlled trial of corticosteroid regimen in endothelial corneal allograft rejection
14. The influence of tissue-type compatibility on the fate of full-thickness corneal grafts
15. Corticosteroids in corneal graft rejection: Double versus single pulse therapy